These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2019-002956-18 Phase 2a Study of ZW25 in Combination with Palbociclib Plus Fulvestrant Estudio de fase 2a de ZW25 en combinación con palbociclib más fulvestrant not-yet-due
Other 2020-000459-11 A Phase 2b, open-label, single-arm study of ZW25 monotherapy in subjects with advanced or metastatic HER2-amplified biliary tract cancers Studio di fase 2b, in aperto, a braccio singolo, su ZW25 ... not-yet-due
Ongoing 2021-000296-36 A Randomized, Multicenter, Phase 3 Study of Zanidatamab in Combination with Chemotherapy with or without Tislelizumab in Subjects with HER2-positive Unresectable Locally Advanced or Metastatic Gastroe... not-yet-due